المؤلفون: Giovannoni, G., Popescu, V., Wuerfel, J., Hellwig, K., Iacobeus, E., Jensen, M. B., García-Domínguez, J. M., Sousa, L., De Rossi, N., Hupperts, R., Fenu, G., Bodini, B., Kuusisto, H. M., Stankoff, B., Lycke, Jan, 1956, Airas, L., Granziera, C., Scalfari, A.

المصدر: Therapeutic Advances in Neurological Disorders. 15

مصطلحات موضوعية: Neurosciences, Neurovetenskaper, multiple sclerosis, progression independent of relapse activity, progressive multiple sclerosis, smouldering multiple sclerosis, alemtuzumab, antioxidant, ascorbic acid, biological marker, Bruton tyrosine kinase, carrier protein, CD68 antigen, deferoxamine, Fc receptor, glutathione, immunoglobulin enhancer binding protein, iron, natalizumab, nitric oxide synthase, ocrelizumab, protein p22, reactive oxygen metabolite, rituximab, thioctic acid, Alzheimer disease, amyotrophic lateral sclerosis, brain atrophy, brain damage, brain size, cellular immunity, central nervous system, clinical outcome, degenerative disease, demyelination, diffusion tensor imaging, disease activity, disease course, disease duration, disease exacerbation, edema, Epstein Barr virus, Expanded Disability Status Scale, gliosis, hematopoietic stem cell transplantation, homeostasis, human, Human endogenous retrovirus, imaging, inflammation, innate immunity, iron chelation, memory B lymphocyte, microglia, myelooptic neuropathy, nerve degeneration, neuroprotection, nuclear magnetic resonance imaging, optic neuritis, oxidative stress, phenotype, positron emission tomography, relapse, Review, rheumatoid arthritis, scoring system, T1 weighted imaging, tissue injury, upregulation, white matter

الوصول الحر: https://gup.ub.gu.se/publication/313649Test

المؤلفون: Sibel Canbaz Kabay, Murat Kürtüncü, Sedat Sen, Pinar Acar, Haluk Gümüş, Murat Terzi, Dilcan Kotan, Özden Kamışlı, Ipek Gungor Dogan, Aksel Siva, Sami Omerhoca, Yusuf Tamam, Serkan Demir, Gokhan Arslan, Destan Bunul, Ahmet Kasim Kilic, Semra Mungan, Tuncay Gündüz, Belgin Petek Balci, Husnu Efendi, Melih Tutuncu, Ugur Uygunoglu, Yeşim Beckmann, Sibel Güler, Levent Sinan Bir, Serhan Sevim, Ömer Faruk Turan, Özgül Ekmekci, Mesrure Koseoglu, Rana Karabudak, Nur Yüceyar, Meltem Demirkiran, Cavid Baba, Serkan Ozakbas, Ayse Altintas, Cihat Uzunköprü, Aslı Tuncer

المساهمون: Altıntaş, Ayşe (ORCID 0000-0002-8524-5087 & YÖK ID 11611), Şen, S., Tuncer, A., Özakbaş, S., Uzunköprü, C., Baba, C., Demir, S., Beckmann, Y., Gümüş, H., Arslan, G., Kılıç, A.K., Yüceyar, N., Turan, O.F., Tütüncü, M., Terzi, M., Acar, P., Bünül, S.D., Balcı, B.P., Bir, L.S., Köseoğlu, M., Mungan, S., Gündüz, T., Doğan, I.G., Kotan, D., Uygunoğlu, U., Ekmekçi, O., Demirkiran, M., Kamışlı O., Kabay, S.C., Tamam, Y., Ömerhoca, S., Sevim, S., Güler, S., Kürtüncü, M., Efendi, H., Karabudak, R., Şiva A., School of Medicine

المصدر: Multiple Sclerosis and Related Disorders

مصطلحات موضوعية: clinical outcome, serology, Disease, myelin oligodendrocyte glycoprotein, myelooptic neuropathy, rituximab, experience, Medicine, azathioprine, biology, Medicine, general and internal, adult, Neuromyelitis Optica, General Medicine, cohort analysis, comorbidity, female, risk factor, Neurology, Comorbid disease, Myelin oligodendrocyte glycoprotein antibody-associated disorders, disease severity, hospitalization, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Coronavirus, Disease modifying treatment, Neuromyelitis optica spectrum disorders, SARS-CoV-2, complication, protein deficiency, Article, Myelin oligodendrocyte glycoprotein, coronavirus disease 2019, male, Disease severity, death, myelin oligodendrocyte glycoprotein antibody associated disorder, Internal medicine, Humans, controlled study, human, Autoantibodies, Aquaporin 4, business.industry, Multiple sclerosis, disease association, COVID-19, medical information, medicine.disease, major clinical study, clinical feature, age, exposure, Neuromyelitis Optica Spectrum Disorders, biology.protein, Myelin-Oligodendrocyte Glycoprotein, Neurology (clinical), disease duration, business, autoantibody

وصف الملف: pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4606dc990be6bde46b1f78b83389bdaaTest
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10262Test

المؤلفون: Turgut, Nilda, Altunan, Bengü, Gündoğdu, Aksoy

مصطلحات موضوعية: Neuromyelitis optica spectrum disorders, P100 amplitude, P100 latency, Pattern reversal visual evoked potentials, Relapsing-remitting multiple sclerosis, aquaporin 4 antibody, immunoglobulin G, adult, aged, Article, blurred vision, clinical article, comparative study, disease duration, electrical potential parameters, Expanded Disability Status Scale, female, human, latent period, male, multiple sclerosis, myelooptic neuropathy, neurophysiology, occipital cortex, optic neuritis, prognosis, retrospective study, treatment planning, visual evoked potential

العلاقة: Yeni Symposium; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.5455/NYS.20200307085847Test; https://hdl.handle.net/20.500.11776/8932Test; 58; 2-s2.0-85096779124

الإتاحة: https://doi.org/20.500.11776/8932Test
https://doi.org/10.5455/NYS.20200307085847Test
https://hdl.handle.net/20.500.11776/8932Test